07.08.2020 - By NEJM Group
Featuring articles on an antisense oligonucleotide for SOD1 ALS, the treatment of familial ALS with a viral vector, angiogenesis and Covid-19, a multifactorial strategy to prevent serious fall injuries, and nemolizumab for atopic dermatitis; a review article on cervical spondylosis; a case report of a homeless man with Covid-19; and Perspective articles on social prescribing; on ensuring choice for people with kidney failure; on disease control, civil liberties, and mass testing; and on coronavirus and the Navajo Nation. Supplement to the New England Journal of Medicine, Vol. 383, No. 2.